top of page

قاعة الشهرة

Friday 27th September

14.00    Check in and Registration

16.00    Afternoon tea and meet-up

18.30    Drinks reception

19.30    Dinner


21.00    Professor Sanjay Popat: Medical Oncologist, The Royal Marsden Hospital and the Charity’s Honorary Clinical Advisor

Saturday 28th September

08.00 – 09.30 Breakfast

09.30    Day Delegate registration

09.45    Welcome & Introduction

Capturev fabio.PNG

10.00    Dr Fabio Gomes:  Medical Oncologist, The Christie Hospital, Manchester: “The ALK Education Project” update.


10.45    Tea/Coffee

11.30    Dr Riyaz Shah: Consultant Medical Oncologist, Kent Oncology: “Circulating tumour DNA”

Capture Reyaz.PNG


12.15    Dr Anna Minchom: Medical Oncologist, The Royal Marsden, lead investigator of the Nuvalent Trial and Clinical Scientist, Institute of Cancer Research: “Clinical Trials”

01.00    Lunch

14.00    Ms Karen Clayton:  Macmillan Lung/Palliative Clinical Nurse Specialist: “What to expect from your CNS”

Capture Clayton.PNG

14.45    Dr Alastair Greystoke: Medical Oncologist, Northern Centre for Cancer Care: “Local Consolidated Therapy”

15.30    Tea/Coffee

16.15    Dr Shobhit Baijal: Medical Oncologist, University Hospital, Birmingham:

 “Questions & Answer Session”

17.00    Close

18.30    Drinks Reception

19.30    Dinner

Sunday 29th September

08.00 – 09.30 Breakfast

10.30    Ms Debra Montague: Chair ALK Positive Lung Cancer UK: “Update from the Charity”

11.00    Tea/Coffee

11.45    Nuvalent, Inc. “The Nuvalent Trial – ALKOVE-1”

12.30    Close & Lunch

09.45    Professor Ben Solomon: Medical Oncologist, Peter MacCallum Cancer Centre, Melbourne, Australia: “Brief history of TKIs and what the future holds for existing patients”

Capture ben.PNG
Deb cc.JPG

This conference will be supported by grants from Roche Products Limited, Pfizer, Takeda, Nuvalent and Guardant.  These companies have had no control over the content of the conference.  

Anyone with lungs can get lung cancer.

bottom of page